# Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/alectinib-in-alk-positive-crizotinib-resistant-non-small-cell-lung-cancer-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Alice T. Shaw,Leena Gandhi,Shirish M. Gadgeel,Gregory J. Riely,Jeremy Cetnar,Howard West,D. Ross Camidge,Mark A. Socinski,Alberto Chiappori,Tarek Mekhail,Bo H. Chao,Hossein Borghaei,Kathryn A. Gold,Ali Zeaiter,Walter Bordogna,Bogdana Balas,Óscar Puig,Volkmar Henschel,Sai‐Hong Ignatius Ou |
| Citations | 641 |
| DOI | 10.1016/s1470-2045(15)00488-x |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://escholarship.org/uc/item/1x24f75r |
| OpenAlex ID | https://openalex.org/W2208535430 |
| PMID | 26708155 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Alice T. Shaw](https://scholariq.org/researchers/alice-t-shaw/)
- [Kathryn A. Gold](https://scholariq.org/researchers/kathryn-a-gold/)
- [Gregory J. Riely](https://scholariq.org/researchers/gregory-j-riely/)
- [Alberto Chiappori](https://scholariq.org/researchers/alberto-chiappori/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.